Direct-to-Patient Platform uses AI to Find gaps in Care

Direct-to-Patient Platform uses AI to Find gaps in Care

Unite Genomics, a Mark Cuban portfolio company, announced a new partnership this week that the company says can help personalize and tailor patient care insights based on their medical records and spot potential gaps in care. The company said Monday that its direct-to-consumer platform uses artificial intelligence to analyze the medical care patients may have received and alert them to missing tests or treatment options. Already in use for ALS, certain cancers and other rare diseases, the technology – enabled by healthcare interoperability requirements on providers – presents a new trend in patient engagement: By offering patients a mechanism to share their medical records and then analyze the treatment data to inform them of potentially missing tests and treatments, Unite's partners take an active role in care conversations.

Medigy Insights

In a letter to the CEOs of Pfizer and Eli Lilly, four senators, led by U.S. Senate Majority Whip Dick Durbin, D-Ill., said they were also concerned about creating the potential for inappropriate prescribing that can increase spending for federal healthcare programs, noting that the Anti-Kickback Statute prohibits the willful payment of remuneration to induce patient referrals for Medicare or Medicaid-covered services or goods.


Deploy this technology today


Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2025 Netspective Foundation, Inc. All Rights Reserved.

Built on Jan 21, 2025 at 3:06pm